Health Tips / Irish Sports Council's Policy on Treatment of Hayfever

Therapeutic Use Exemption (TUE) Committee Policy on Glucocorticosteroid Injections for Hay Fever

(updated 11th March 2013)

Depo-Medrone (Methylprednisolone) and Kenalog (Triamcinolone) administered by intra-muscular injection as treatment for hay fever are prohibited in sport and therefore their use requires the athlete and their physician to strictly adhere to the TUE Policy. The TUE Policy is available at www.irishsportscouncil.ie/tue.

-Athletes included in their International Federation Registered Testing Pool and/or athletes competing at International Competition will require a Therapeutic Use Exemption in advance of using an intra-muscular glucocorticosteroid. These athletes should contact their sport’s Anti-Doping Officer for assistance in identifying International Competitions and establishing the requirements for a TUE Application.

-Athletes included in the Irish Sports Council Registered Testing Pool that are not competing at an International Competition should apply to the Irish Sports Council for a Pre-test Therapeutic Use Exemption, using the information in the Medical File section below to aid them, prior to using an intra-muscular glucocorticosteroid.

-Athletes eligible for a post-test TUE application (see www.irishsportscouncil.ie/tue) should ensure that they are capable of providing a medical file to the standard outlined below, prior to the administration of any intra-muscular glucocorticosteroid injection by a physician. Athletes may be required to submit this medical file to support a TUE application at a later date.

Medical File

Intra-muscular glucocorticosteroid TUE applications MUST be accompanied by a medical file reflecting current best medical practice to include:

1. A complete medical history i.e. when the hay fever began; the associated symptoms, their severity and effect on sporting performance; and symptoms suffered in previous hay fever episodes.
2. Clinical evidence of attempting to use alternative permitted oral, nasal and/or ophthalmic medications and justification as to why alternative permitted medications are not sufficient.
3. Copies of all relevant examinations, laboratory results/reports and clinical notes (for example, if a clinic visit is referenced in a letter or summary, a copy of the clinical notes taken during the visit must be submitted); provide details of any known allergens or allergic history including results of any previous immunological testing.
4. Exact name, speciality, address (including telephone, e-mail, fax) of examining physician

Athletes and their physicians are reminded that there are a number of permitted medications, both over-the-counter and prescribed, that can be used for the treatment of hay fever (as checked on the Drugs in Sport Database on www.eirpharm.com, 04^th March 2013) such as:

Over-the-counter medications

• Oral: e.g. Cetirelief Allergy, Clarityn, Zirtek, Lorat
• Nasal drop/spray: e.g. Otrivine nasal drops, Otrivine nasal spray, Nasobec Allergy nasal spray
• Eye drops: e.g. Otrivine Antistin eye drops, Vividrin Antiallergic eye drops

Prescribed medications

• Oral: e.g. Neoclarityn, Telfast, Grazax, Oralair
• Nasal spray: e.g. Avamys nasal spray, Rhinolast nasal spray, Nasonex nasal spray

Note: While Kenalog Injection has been discontinued from the Irish market some unlicensed product may be available.

• Anti-Doping: 2025 Guide for Prescribers
• Athletes Fluid Requirements
• Changes to the Prohibited List 2025
• Drugs abuse in sports
• Ephedra prohibited in the US
• IOC Study on Sports Supplements
• Irish Sports Council's Policy on Treatment of Hayfever
• Nandrolone
• Supplements
• THG
• What is EPO?